Onsite Women’s Health, a leading national provider of breast health services, today announced the appointment of Melissa Morris as the company’s Senior Vice President of Operations, effective immediately.
A more than 20-year healthcare veteran, Melissa brings an exceptional track record of operational leadership from companies such as AMSURG and Inform Diagnostics, and a passion for women’s healthcare. In this role, she will be responsible for the P&L-led center governance, operations, budgets and administrative oversight for more than 115 partner locations, leading a team focused on operational excellence and delivering a best-in class patient and practice partner experience.
“I am delighted to announce that Melissa Morris has joined Onsite Women’s Health as Senior Vice President of Operations,” said Jillian Wright, chief executive officer at Onsite Women’s Health. “Her skills and experience enable Onsite to continue to scale the organization and our breast health service offerings nationwide.”
Prior to joining Onsite, Melissa served as the Regional Vice President of Operations at AMSURG where she led a workforce of 400+ employees across Pennsylvania, Maryland and Connecticut in the ambulatory 
surgery center sector.
“I am excited about the opportunity to serve Onsite Women’s Health in this new role,” said Melissa. “I believe in the mission and vision of this company, and I’m eager to contribute to its continued growth and successproviding state-of-the-art breast imaging services.”
Melissa completed the Healthcare IT Accelerator Program at Belmont University, and holds a bachelor’s degree in business administration from the University of Texas at Dallas. She and her husband, Ryan, live in Mount Juliet, Tennessee, and have two children, Ethan and Emma.
About Onsite Women’s Health
In partnership with forward-thinking providers across the country, Onsite Women’s Health offers comprehensive breast imaging services – including 3D screening mammography, automated screening breast ultrasound, diagnostic mammography/breast ultrasound, and lifetime breast cancer risk assessment. Onsite is committed to saving more women’s lives through earlier cancer detection and is materially impacting breast cancer screening compliance and detection rates through offering convenient access to mammography, contracting with breast-focused radiologists, and utilizing the most innovative equipment and AI-powered technology available on the market. By offering the ability to risk assess patients using tools powered by AI, Onsite supports the providers’ ability to offer personalized and precise care plans to patients based on individual risk profiles. Onsite services increase patient satisfaction, improve breast health services, and offer an additional revenue opportunity for practice partners. Since its founding in 2008, Onsite has performed more than two million exams across 26 states.